EURONEX

• Active substance: tranexamic acid: 100 mg/ml

  Medicinal form: Solution for injection.

  Indications for use:
  Bleeding or risk of bleeding with increased fibrinolysis, both generalised and local, in adults and children over 1 year of age.

  Registration certificate: UA/18021/01/01